期刊文献+

TLR9激动剂CpG-ODN对HepG2肝癌细胞增殖及侵袭的影响 被引量:1

The Influence of the Activator Cp G- ODN of TLR9 on the Proliferation and Invasion of Hepatocellular Cancer Cells Hep G2
下载PDF
导出
摘要 目的探讨Toll样受体9(TLR9)激动剂未甲基化的胞嘧啶-鸟嘌呤核苷酸序列(Cp G-ODN)对Hep G2肝癌细胞增殖及侵袭的影响。方法应用不同浓度的Cp G-ODN作用于肝癌细胞株Hep G2不同时间,采用实时荧光定量PCR法检测Hep G2中TLR9mRNA表达情况,MTT法检测Hep G2细胞的增殖变化,Transwell法检测其侵袭能力变化。结果 Cp G-ODN组(4、16μg·m L-1)与阴性对照组比较可增加Hep G2细胞中TLR9mRNA的表达;Cp G-ODN(1、4、16μg·m L-1)激动TLR9后可促进Hep G2细胞增殖,且以48h最为显著,并存在剂量依赖关系;Cp G-ODN(4、16μg·m L-1)激动TLR9可增强Hep G2细胞的侵袭能力(P均<0.05)。结论 TLR9表达上调可促进肝癌细胞增殖和侵袭。 Objective To investigate the influence of the activator Cp G- ODN of TLR9 on the proliferation and invasion of hepatocellular cancer cells Hep G2. Methods Cp G- ODN with different concentration was administered to the hepatocellular cancer cells Hep G2. The expression of TLR9 mRNA was detected by real-time PCR and the proliferation of Hep G2 cells were determinded by MTT assay while the changes of invasion ablity were monitored by transwell assay. Results Cp G- ODN( 4,16μg·m L^-1) could significantly increase the TLR9 mRNA expression level compared with the negative control group. The proliferation of Hep G2 cells could be promoted when TLR9 was activated by Cp G- ODN( 1,4,16μg·m L^-1) and the most obvious change was at the 48 h point,which was a dose- dependent manne. The invasion ability of Cp G- ODN( 4,16μg·m L^-1) was significantly enhanced by TLR9( P〈0. 05). Conclusion Upregulation of TLR9 can promote proliferation and invasion in hepatocellular cancer cells.
出处 《宁夏医科大学学报》 2015年第4期397-399,412,F0004,共5页 Journal of Ningxia Medical University
关键词 TOLL样受体9 肝癌细胞 HEP G2 胞嘧啶-鸟嘌呤核苷酸序列 Toll-like receptors 9 hepatoma cells Hep G2 Cp G-ODN
  • 相关文献

参考文献12

  • 1Merrell Ma, Ilvesar Jm, Lehtonen N, et al. Toll - like receptor 9 agonists promote cellular invasion by in- creasing matrix metalloproteinase activity [ J ]. Mol Cancer Res ,2006,4:437 -447.
  • 2Krieg Am. Therapeutic potential of toll - like receptor 9 activation [ J ]. Nat Rev Drug Discov ,2006,5:471 - 84.
  • 3E1 -Serag HB. Epidemiology of viral hepatitis and hep- atocellular carcinoma[ J]. Gastroenterology ,2012,142 : 1264 - 1273.
  • 4Chen R, Alvero Ab, Silasida Da, et al. Cancers take their toll - the function and regulation of toll - like re- ceptors in cancer cells [ J ]. Oncogene, 2008, 27: 225 - 233.
  • 5Huang B ,Zhao J, Unkeless JC, et al. TLR signaling by tumor and immune cells : a double - edged sword [ J ]. Oncogene,2008 ,27 :218 - 224.
  • 6Eiro N, Altadill A, Juarez Lm, et al. Toll - like recep- tors 3,4 and 9 in hepatocellular carcinoma: Relation- ship with clinicopathological characteristics and prog- nosis [ J ]. Hepatology Research, 2014, 44 ( 7 ) : 769 - 778.
  • 7Tanaka J, Sugimoto K, Shiraki K, et al. Functional cell surface expression of toll - like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas [ J ]. International Journal of Oncology, 2010,37(4) :805.
  • 8Honda K,Yanai H,Mizutani T. Role of a tmnsductional - transcriptional processor complex involving MyD88 and IRF- 7 in toll -like receptor signaling[ J ]. Proe Natl Acad Sci USA ,2004,101 : 15416 - 15421.
  • 9Kawai T, Sato S, Ishii KJ. Interferon - alpha induction through Toll - like receptors involves a direct interac- tion of IRF7 with MyD88 and TRAF6 [ J ]. Nat Immu- nol,2004,5 : 1061 - 1068.
  • 10Ning S, Pagano JS, Barber GN. IRF7 : activation, regu- lation, modification and function [ J ]. Genes and im- munity,2011,12(6) :399 -414.

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部